The company
Arcutis Biotherapeutics, Inc.
ARQT · Nasdaq
ARQT stood above a rising 150-day average in 22 of the last 52 weekly readings, including each of the last 2 weeks. It is 25.0% above that average now. Biotechnology: 17% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 27% (−6 points in four weeks).
Statistics
- Last close, 22 Oct 2026
- 32.2 +1.04%
- 52-week range
- —
- Volume
- 2.08M
- Average volume (50 days)
- —
- Relative volume
- —
- Rotation
- Just started moving
- Weeks in an uptrend
- 2 in a row
- Industry in uptrend
- 17% -9 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $25.1M
- Officials’ trades on record
- 6
- Institutions holding
- 258 (+6)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 22 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Price and volume
Daily bars to 22 Oct 2026: 29 sessions (1Y reaches back before the first session held here, 11 Sep 2026, so this is all of them). 1D is the last two sessions and 1W the last week of the same daily bars; nothing here is intraday.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
6 disclosed lines: House 6, Senate 0, executive 0; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 29 May 2026filed 8 Jun 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 3 Mar 2026filed 7 Apr 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | sold | $1k–$15k | 11 Dec 2025filed 12 Jan 2026 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 15 Sep 2023filed 15 Oct 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 17 Apr 2023filed 19 May 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 15 Jun 2022filed 22 Jul 2022 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Howard G. WelgusDirector | sold | 4,728at $26.93 | 15 Oct 2026filed 19 Oct 2026 |
| Masaru MatsudaOfficer | sold | 3,674at $25.00 | 16 Sep 2026filed 18 Sep 2026 |
| Howard G. WelgusDirector | sold | 4,730at $24.18 | 15 Sep 2026filed 17 Sep 2026 |
| Masaru MatsudaOfficer | sold | 9,989at $25.03 | 8 Sep 2026filed 10 Sep 2026 |
| Terrie CurranDirector | sold | 11,148at $25.03 | 27 Aug 2026filed 28 Aug 2026 |
| Terrie CurranDirector | sold | 27,052at $25.03 | 27 Aug 2026filed 28 Aug 2026 |
| Terrie CurranDirector | sold | 1,072at $26.04 | 20 Aug 2026filed 24 Aug 2026 |
| Patrick BurnettOfficer | sold | 1,697at $27.00 | 19 Aug 2026filed 21 Aug 2026 |
| Howard G. WelgusDirector | sold | 4,730at $26.18 | 17 Aug 2026filed 19 Aug 2026 |
| Patrick BurnettOfficer | sold | 6,700at $26.08 | 12 Aug 2026filed 13 Aug 2026 |
| Patrick BurnettOfficer | sold | 8,300at $26.52 | 11 Aug 2026filed 13 Aug 2026 |
| Todd WatanabeDirector, Officer | sold | 4,375at $26.12 | 3 Aug 2026filed 5 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| MONTANOVA CAPITAL, LLCadded · filed 14 Aug 2026 | 12,437,000$326.1M | +110,000+0.9% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 10,545,466$276.5M | +1,345,055+14.6% |
| Frazier Life Sciences Management, L.P.unchanged · filed 14 Aug 2026 | 9,874,511$258.9M | 00.0% |
| Rubric Capital Management LPunchanged · filed 14 Aug 2026 | 8,271,577$216.9M | 00.0% |
| Polar Capital Holdings Plcadded · filed 14 Aug 2026 | 6,606,945$173.2M | +940,005+16.6% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 5,822,840$152.7M | -473,357−7.5% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 4,988,756$130.8M | +117,220+2.4% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 4,451,014$116.7M | +232,083+5.5% |
| JENNISON ASSOCIATES LLCreduced · filed 3 Aug 2026 | 4,219,058$110.6M | -761,712−15.3% |
| D. E. Shaw & Co., Inc.added · filed 14 Aug 2026 | 3,949,609$103.6M | +1,453,387+58.2% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.